The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Potassium channel antibodies in two patients with reversible limbic encephalitis
Abstract
Limbic encephalitis (LE) is often associated with lung, thymic, or testicular tumours and antibodies to Hu, CV2, or Ma2 (Ta) antigens. In these cases, it generally has a poor prognosis. Here we describe two patients with symptoms of LE, negative for typical paraneoplastic antibodies, in whom antibodies to voltage‐gated potassium channels (VGKC) were detected retrospectively in serial serum samples. Patient 1 had a thymoma recurrence, but in patient 2 no tumour has been detected in the years following presentation. Plasma exchange was effective in reducing VGKC antibody levels, with substantial improvement in mental symptoms in patient 1. In patient 2, the VGKC antibodies fell spontaneously over two years, with almost complete recovery of mental function. Although neither patient had obvious neuromyotonia at presentation, both showed excessive secretions. We suggest that patients with limbic symptoms and excessive secretions should be tested for VGKC antibodies, and, if they are present, prompt and effective immunosuppressive treatment should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
Selnes, O. A. (1991) · Neurology · doi:10.1212/wnl.41.11.1856-a · Cited by 2,252
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
The Ionic Channels in Excitable Membranes
Keynes, R. D. (1975) · Novartis Foundation Symposia · doi:10.1002/9780470720134.ch11 · Cited by 1,648
Kopelman, M. D., Wilson, B. A., & Baddeley, A. D. (1989) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638908400928 · Cited by 937
Deletion of the KV1.1 Potassium Channel Causes Epilepsy in Mice
Smart, S. L., Lopantsev, V., Zhang, C. L., Robbins, C. A., Wang, H., Chiu, S. Y., Schwartzkroin, P. A., Messing, A., & Tempel, B. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)81018-1 · Cited by 599
“LIMBIC ENCEPHALITIS” AND ITS ASSOCIATION WITH CARCINOMA
CORSELLIS, J. A. N., GOLDBERG, G. J., & NORTON, A. R. (1968) · Brain · doi:10.1093/brain/91.3.481 · Cited by 491
Vincent, A., & Newsom-Davis, J. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.12.1246 · Cited by 471
Self-citationVoltz, R., Gultekin, S. H., Rosenfeld, M. R., Gerstner, E., Eichen, J., Posner, J. B., & Dalmau, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402303 · Cited by 379
Zuberi, S. M. (1999) · Brain · doi:10.1093/brain/122.5.817 · Cited by 366
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia
Hart, I. K., Waters, C., Vincent, A., Newland, C., Beeson, D., Pongs, O., Morris, C., & Newsom‐Davis, J. (1997) · Annals of Neurology · doi:10.1002/ana.410410215 · Cited by 315
Self-citation
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Irani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A. (2010) · Brain · doi:10.1093/brain/awq213 · Cited by 1,359
Self-citationFatigue in neurological disorders
Chaudhuri, A., & Behan, P. O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15794-2 · Cited by 1,297
Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
Self-citationIrani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
“These patients do not usually have an underlying neoplasm, and do well following immunotherapies, with a substantial and sometimes complete recovery (Buckley et al., 2001; Thieben et al., 2004; Vincent et al., 2004).”
InfluentialSelf-citationSchwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
Lancaster, E., Huijbers, M. G. M., Bar, V., Boronat, A., Wong, A., Martinez‐Hernandez, E., Wilson, C., Jacobs, D., Lai, M., Walker, R. W., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22297 · Cited by 737
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Schwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Autoantibodies associated with diseases of the CNS: new developments and future challenges
Vincent, A., Bien, C. G., Irani, S. R., & Waters, P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70096-5 · Cited by 542
Self-citationMorvan syndrome: Clinical and serological observations in 29 cases
Irani, S. R., Pettingill, P., Kleopa, K. A., Schiza, N., Waters, P., Mazia, C., Zuliani, L., Watanabe, O., Lang, B., Buckley, C., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23577 · Cited by 540
Self-citationInfections, inflammation and epilepsy
Vezzani, A., Fujinami, R. S., White, H. S., Preux, P.-M., Blümcke, I., Sander, J. W., & Löscher, W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1481-5 · Cited by 518
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A., Houghton, D. J., Galetta, S. L., Dichter, M., Alavi, A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 488
Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Tüzün, E., & Dalmau, J. (2007) · The Neurologist · doi:10.1097/nrl.0b013e31813e34a5 · Cited by 478
Self-citationThe clinical spectrum of Caspr2 antibody–associated disease
van Sonderen, A., Ariño, H., Petit-Pedrol, M., Leypoldt, F., Körtvélyessy, P., Wandinger, K.-P., Lancaster, E., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002917 · Cited by 441
Irani, S. R., Stagg, C. J., Schott, J. M., Rosenthal, C. R., Schneider, S. A., Pettingill, P., Pettingill, R., Waters, P., Thomas, A., Voets, N. L., et al. (2013) · Brain · doi:10.1093/brain/awt212 · Cited by 437
Self-citationUnravelling the pathogenesis of myasthenia gravis
Vincent, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri916 · Cited by 414
Self-citationLiguori, R. (2001) · Brain · doi:10.1093/brain/124.12.2417 · Cited by 407
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., & Vernino, S. (2004) · Neurology · doi:10.1212/01.wnl.0000122648.19196.02 · Cited by 394
Amphiphysin autoimmunity: Paraneoplastic accompaniments
Pittock, S. J., Lucchinetti, C. F., Parisi, J. E., Benarroch, E. E., Mokri, B., Stephan, C. L., Kim, K., Kilimann, M. W., & Lennon, V. A. (2005) · Annals of Neurology · doi:10.1002/ana.20529 · Cited by 369
Autoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy
Quek, A. M. L. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2985 · Cited by 359
Disease-relevant autoantibodies in first episode schizophrenia
Zandi, M. S., Irani, S. R., Lang, B., Waters, P., Jones, P. B., McKenna, P., Coles, A. J., Vincent, A., & Lennox, B. R. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5788-9 · Cited by 319
Self-citationZuliani, L., Graus, F., Giometto, B., Bien, C., & Vincent, A. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301237 · Cited by 293
Self-citationClinical spectrum of voltage-gated potassium channel autoimmunity
Tan, K. M., Lennon, V. A., Klein, C. J., Boeve, B. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000312275.04260.a0 · Cited by 281
The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis
van Sonderen, A., Petit-Pedrol, M., Dalmau, J., & Titulaer, M. J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.43 · Cited by 272
Hacohen, Y., Wright, S., Waters, P., Agrawal, S., Carr, L., Cross, H., De Sousa, C., DeVile, C., Fallon, P., Gupta, R., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303807 · Cited by 269
Self-citationGeschwind, M. D., Haman, A., & Miller, B. L. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.04.001 · Cited by 143
Psychiatric Manifestations of Paraneoplastic Disorders
Kayser, M. S., Kohler, C. G., & Dalmau, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101547 · Cited by 129
Metadata
- Authors
- Buckley, C., Oger, J., Clover, L., Tüzün, E., Carpenter, K., Jackson, M., & Vincent, A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2001-06-26
- Volume
- 50
- Issue
- 1
- Pages
- 73-78
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1996510251
- Cited by
- 444
- References
- 17
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.